X T L Biopharmaceuticals reported $420K in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 595K 218K Mar/2026
Bioline Rx USD 13.62M 1.5M Mar/2026
Teva Pharmaceutical Industries USD 15.65B 2.11B Jun/2026
X T L Biopharmaceuticals USD 420K 341K Dec/2025